Dysadipocytokinemia in Werner Syndrome and Its Recovery by Treatment With Pioglitazone-Reference-Cited by-同舟云学术

Dysadipocytokinemia in Werner Syndrome and Its Recovery by Treatment With Pioglitazone

Published:2004-10-01 Issue:10 Volume:27 Page:2562-2563
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Yokote Koutaro¹²,Hara Kazuo³,Mori Seijiro¹²,Kadowaki Takashi³,Saito Yasushi¹²,Goto Makoto⁴⁵

Affiliation:

1. Division of Endocrinology and Metabolism, Department of Internal Medicine, Chiba University Hospital, Chiba City, Japan

2. Department of Clinical Cell Biology, Chiba University Graduate School of Medicine, Chiba City, Japan

3. Department of Metabolic Diseases, Graduate School of Medicine, University of Tokyo, Tokyo, Japan

4. Department of Rheumatology, Tokyo Metropolitan Otsuka Hospital, Tokyo, Japan

5. Institute of Bioengineering, Toin Yokohama University, Yokohama, Japan

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/27/10/2562/562016/2562.pdf

Reference5 articles.

1. Goto M: Clinical characteristics of Werner syndrome and other premature aging syndromes: pattern of aging in progeroid syndromes. In From Premature Gray Hair to Helicase-Werner Syndrome: Implication for Aging and Cancer. Goto M, Miller RW, Eds. Basel, Karger, 2001, p. 27–39

2. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941–946, 2001

3. Mori S, Murano S, Yokote K, Takemoto M, Asaumi S, Take A, Saito Y: Enhanced intra-abdominal visceral fat accumulation in patients with Werner’s syndrome. Int J Obes Relat Metab Disord 25:292–295, 2001

4. Daimon M, Oizumi T, Saitoh T, Yamaguchi H, Hirata A, Ohnuma H, Igarashi M, Eguchi H, Manaka H, Tominaga M: Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population. Diabetes Care 26:2015–2020, 2003

5. Yokote K, Honjo S, Kobayashi K, Fujimoto M, Kawamura H, Mori S, Saito Y: Metabolic improvement and abdominal fat redistribution in Werner syndrome by pioglitazone (Letter). 52:1582–1583, 2004

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Senescence-associated inflammation and inhibition of adipogenesis in subcutaneous fat in Werner syndrome;Aging;2023-10-03

2. Clinical and Basic Biology of Werner Syndrome, the Model Disease of Human Aging;Aging Mechanisms II;2022

3. Werner syndrome: A rare cause of young-onset diabetes;Journal of Diabetology;2021

4. Management guideline for Werner syndrome 2020. 3. Diabetes associated with Werner syndrome;Geriatrics & Gerontology International;2020-11-09

5. Facial Fat Fitness: A New Paradigm to Understand Facial Aging and Aesthetics;Aesthetic Plastic Surgery;2020-09-10